Drugs / GPC3 Targeting CART Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05352542 | May 2022 → Jul 2024 | hepatocellular carcinoma | jianming xu | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GPC3 Targeting CART Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05352542 ↗ |
| Modality | Cell therapy | “GPC3 Targeting CART Cells” NCT05352542 ↗ |
| Target | GPC3 | “GPC3-targeting CART Cell” NCT05352542 ↗ |